Psoriatic Arthritis
News
New tool aims to improve monitoring of psoriatic arthritis
Key clinical point: A brief, five-question assessment tool may be a good way to routinely monitor psoriatic arthritis patients. Major finding: The...
News
Older psoriasis patients experience more adverse events
News
Late-onset psoriasis genetics identified
News
New psoriatic arthritis screening tool passes initial validation
News
Psoriatic arthritis associated with heavy drinking
Conference Coverage
Apremilast meets psoriasis endpoints at week 32
Key clinical point: Oral apremilast beat placebo and showed durable efficacy in patients with moderate to severe plaque psoriasis. Major finding:...
Conference Coverage
Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks
Key clinical point: The investigational anti-IL-17A antibody ixekizumab met its endpoints at week 12 in patients with plaque psoriasis, and showed...
Conference Coverage
IL-23 inhibitor topped ustekinumab against psoriasis
Key clinical point: The interleukin-23 inhibitor BI 655066 outperformed ustekinumab and generated no concerning safety signals in a small phase II...
News
Traditional risk factors raise cardiovascular risk in PsA
Key clinical point: The increased risk of cardiovascular disease in psoriatic arthritis is largely because of an increased prevalence of...
News
No increased risk of lung disease with methotrexate
Key clinical point: Methotrexate is not associated with an increased risk of pulmonary disease. Major finding: There was no increased risk of...
News
Methotrexate and biologics linked to higher zoster risk in psoriasis
Key clinical point: The combination of methotrexate and biologics for the treatment of psoriasis may increase the risk of herpes zoster infection...